WFDC2 and lung carcinoma: The effect prognostic effects of HE4 in other cancers, such as endometrial cancer and lung cancer has not been sufficiently investigated.[15,16] The proposed study is designed to ameliorate this issue by conducting a comprehensive systematic review and meta-analysis of all currently published literature on the prognostic and diagnostic utility of HE4 biomarker in relevant cancers.